BioSpace News Archive

ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumor cell diagnostic solutions for the research and diagnostic oncology market, announces its unaudited interim financial results for the six months ended 30 June 2023.

Actimed Therapeutics Ltd announces that it has received approval from the US FDA for its IND application for one Phase 2b/3 clinical study of S-pindolol benzoate to treat cachexia associated with colorectal cancer and another in patients with non-small cell lung cancer.

Cerba HealthCare, a leading global player in medical diagnosis, announced it has acquired CIRION BIOPHARMA RESEARCH INC, a Canadian-controlled private company highly recognized for its integrated bioanalytical and global central laboratory services.

Medivir AB announces that data on the company’s leading program fostroxacitabine bralpamide and its potential effect on hepatocellular carcinoma, will be presented at the International Liver Cancer Association Annual Meeting, September 7-9 in Amsterdam.

Ohh-Med Medical, a medtech startup located in the Tiberias Industrial Zone, has recently launched Ohh-Med UK, a wholly owned subsidiary located in England, to sell, market, and support sales of the Vertica medical device throughout the United Kingdom.

Opthea Limited announced that Mr. Tim Morris, the Company’s Chief Financial Officer will present at H.C. Wainwright’s 25th Annual Global Investment Conference being held at the Lotte New York Palace Hotel in New York City on September 11th – 13th, 2023.

Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will both present and participate in a conference panel at the H.C. Wainwright 25th Annual Global Investment Conference, taking place September 11-13, 2023 virtually and in New York City, New York.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced three new Contract Research Organization CosMxTM Spatial Molecular Imager partnerships.

Vivani Medical, Inc. announced that it will present at the upcoming Annual Boulder Peptide Symposium at 11:20 am PST at the Napa Valley Marriott Hotel and Spa in Napa, California on September 19, 2023.

Affimed N.V. announced that its Chief Executive Officer, Dr. Adi Hoess, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 11:00 a.m. Eastern Daylight Time / 17:00 Central European Time.